Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
1.060
-0.060 (-5.36%)
At close: Dec 5, 2025, 4:00 PM EST
1.050
-0.010 (-0.93%)
After-hours: Dec 5, 2025, 7:36 PM EST
Lexaria Bioscience Ratios and Metrics
Market cap in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 5, 2025 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| Market Capitalization | 24 | 17 | 62 | 8 | 18 | 35 | |
| Market Cap Growth | -31.31% | -72.15% | 627.66% | -51.77% | -50.18% | 13.53% | |
| Enterprise Value | 22 | 12 | 53 | 5 | 10 | 27 | |
| Last Close Price | 1.12 | 0.88 | 3.91 | 1.05 | 2.96 | 6.22 | |
| PS Ratio | 28.56 | 24.39 | 133.15 | 37.56 | 68.97 | 48.92 | |
| PB Ratio | 7.33 | 6.62 | 8.07 | 3.17 | 2.31 | 2.71 | |
| P/TBV Ratio | 9.03 | 6.42 | 8.22 | 3.29 | 2.36 | 2.74 | |
| EV/Sales Ratio | 31.65 | 17.46 | 114.33 | 21.58 | 39.44 | 37.19 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.02 | 0.06 | 0.01 | 0.01 | |
| Asset Turnover | 0.11 | 0.11 | 0.08 | 0.04 | 0.02 | 0.09 | |
| Inventory Turnover | - | - | - | - | 2.11 | 2.39 | |
| Quick Ratio | 1.56 | 1.56 | 6.10 | 5.99 | 32.79 | 78.90 | |
| Current Ratio | 2.32 | 2.32 | 7.18 | 8.04 | 35.96 | 81.18 | |
| Return on Equity (ROE) | -232.15% | -232.15% | -112.36% | -130.18% | -71.35% | -73.16% | |
| Return on Assets (ROA) | -111.49% | -111.49% | -59.56% | -73.59% | -39.21% | -44.17% | |
| Return on Capital (ROIC) | -138.38% | -138.38% | -66.91% | -76.32% | -39.70% | -44.99% | |
| Return on Capital Employed (ROCE) | -433.80% | -433.80% | -73.30% | -228.20% | -86.60% | -43.40% | |
| Earnings Yield | -49.17% | -69.13% | -9.38% | -78.45% | -41.27% | -11.39% | |
| FCF Yield | -43.28% | -60.84% | -8.09% | -69.63% | -27.98% | -11.28% | |
| Buyback Yield / Dilution | -45.34% | -45.34% | -87.24% | -12.38% | -34.02% | -58.34% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.